Warning letter
Hawkins, Inc.: warning letter of Sep 8, 2006
FDA warning letter UCM076059 · Minneapolis District Office
Key facts
| Reference number | UCM076059 |
|---|---|
| Company | Hawkins, Inc. |
| Subject | CGMP Active Pharmaceutical Ingredient |
| Issue date | Sep 8, 2006 |
| Posted date | Sep 8, 2006 |
| Issuing office | Minneapolis District Office |
| Product type | Drugs |
| CFR sections cited | 310.502(a)(11) |
| Country | 3 |
| Inspection city | Minneapolis |
| Inspection ZIP | 55413-2922 |
| Inspection start date | Mar 28, 2006 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: